The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines.

The AHA is expanding its initiative to improve detection, standardize care, and enhance treatment for hypertrophic cardiomyopathy.

Age-related hearing loss (ARHL) and tinnitus are associated with worse physical, psychological, and social health.

Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

The American Heart Association launched a new Heart Valve Initiative to eliminate delays in valvular heart disease diagnosis and treatment.

The U.S. Centers for Disease Control and Prevention (CDC) reported that COVID vaccines reduced the risk of ER visits by 76% in kids under age 4 and by 56% in kids ages 5 to 17 during the first six ...

Sleep length and quality suffer from environmental stressors like heat, which can increase the risk of disease and even death.

The FDA has approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy to treat patients with SAA.

HRS/ACC statement guides expanded access for intracardiac ablation procedures in ambulatory surgical centers for appropriate patients.

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care for opioid use disorder.

Long-term exposure to polluted air can weaken the health benefits of regular exercise on all-cause, cardiovascular, and cancer mortality.